NOT-HL-19-721: Notice of Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for NHLBI RFA-HL-20-026 "Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) Research Coordinating Center (RCC) (U24)

Notice of Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for NHLBI RFA-HL-20-026 "Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) Research Coordinating Center (RCC) (U24)

Notice Number: NOT-HL-19-721

Key Dates
Release Date: October 8, 2019

Related Announcements

RFA-HL-20-026 : Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) Research Coordinating Center (U24 - Clinical Trial Not Allowed)

RFA-HL-20-025: Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) (UG3/UH3 - Clinical Trial Optional)

NOT-HL-17-521: Notice of Intent to Publish a Funding Opportunity Announcement for Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV Data Coordinating Center (HLB SIMPLe DCC) (U24)

NOT-HL-17-520: Notice of Intent to Publish a Funding Opportunity Announcement for Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) (U01)

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

On October 2, 2019, the National Heart, Lung, and Blood Institute (NHLBI) and the Fogarty International Center (FIC) issued a Funding Opportunity Announcement (FOA): RFA-HL-20-026, entitled " Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) Research Coordinating Center (RCC) (U24 - Clinical Trial Not Allowed).

A pre-submission technical assistance webinar is being offered to inform potential applicants about RFA-HL-20-026 (HLB SIMPLe RCC (U24)) and will include a review of the purpose and objectives of this FOA, application and peer review requirements, and budget considerations.

All prospective applicants are invited to attend and are strongly encouraged to send relevant questions prior to the webinar in order to maximize the use of time. Specific questions should be sent via email to ctrisgrants@nih.gov no later than 48 hours prior to the webinar.

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-HL-20-026 .

Session Date and time is as follows:

Thursday, October 24, 2019 at 8:30 a.m. EDT

Join WebEx

Event number: 627 473 755
Event password: simple
Event address for attendees: https://nih.webex.com/nih/onstage/g.php?MTID=eb55e6c65bd42e38ed9ab7425f7e6f46c

Join the Audio Conference

Call-in toll number (US/Canada): 1-650-479-3208

Global call-in numbers: https://nih.webex.com/nih/globalcallin.php?serviceType=EC&ED=809509702&tollFree=0

Access code: 627 473 755

This Notice also provides information regarding the availability of Frequently Asked Questions (FAQs) to address common questions from potential applicants regarding RFA-HL-20-026, which are available at: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/rfa-hl-20-026.

All applicants are encouraged to review the FAQs prior to submitting an application. The FAQs may be updated, as needed. Applicants are encouraged to check for updates to the FAQs regularly until the submission date.

Inquiries

Please direct all inquiries to:

Brad Newsome, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8170
Email: brad.newsome@nih.gov

Geetha P. Bansal, Ph.D.
Fogarty International Center (FIC)
Telephone: 301-496-1492
Email: geetha.bansal@nih.gov